Progress Seen in Proportion of Pregnant Persons With Hep C Screening
There has been substantial progress in the proportion of pregnant persons screened for hepatitis C virus (HCV) infection.
There has been substantial progress in the proportion of pregnant persons screened for hepatitis C virus (HCV) infection.
Researchers assessed the effectiveness of both sofosbuvir/velpatasvir and gelcaprevir/pibrentasvir among patients infected with hepatitis C genotype 6.
Researchers assessed whether CD4+ T-cell count predicts treatment outcomes in patients with cancer who received direct-acting antivirals for hepatitis C.
In a study, aviremic recipients of HCV-positive and HCV-negative deceased donor kidneys had similar 12-month transplant outcomes.
A team of researchers analyzed the virologic response of hepatitis C virus to direct-acting antivirals in patients with HIV.
Researchers assessed the effect of preoperative antiviral treatment for hepatitis C virus on the risk for surgical-related complications in patients who underwent total joint arthroplasty.
Researchers assessed the characteristics and distribution of hepatitis C virus (HCV) genotypes among individuals with confirmed HCV infection who donated blood during a 16-year period.
Researchers assessed whether the rate of treatment initiations for hepatitis C virus infection among patients participating in a methadone treatment program increased after the implementation of a hepatology clinic.
Researchers assessed the safety and efficacy of sofosbuvir-velpatasvir in patients with chronic hepatitis C virus in Rwanda.
Researchers conducted a study to determine whether the addition of a default screening order in the electronic health record increases the rate of hepatitis C virus screening among hospitalized patients.